Clinical Outcome of the ACCORD 12/0405 PRODIGE 2 Randomized Trial in Rectal CancerJean‐Pierre Gérard, Thierry Conroy, Christophe Hennequin et al.|Journal of Clinical Oncology|2012Cited by 431
<i>In vivo</i> Therapeutic Synergism of Anti–Epidermal Growth Factor Receptor and Anti-HER2 Monoclonal Antibodies against Pancreatic CarcinomasChristel Larbouret, D. Azria|Clinical Cancer Research|2007Cited by 84
Combined cetuximab and trastuzumab are superior to gemcitabine in the treatment of human pancreatic carcinoma xenograftsChristel Larbouret, D. Azria|Annals of Oncology|2009Cited by 49
Analysis of Circulating Tumor Cells in Patients with Non-Metastatic High-Risk Prostate Cancer before and after Radiotherapy Using Three Different Enumeration AssaysJoanna Budna, Catherine Alix‐Panabières, Monika Świerczewska et al.|Cancers|2019Cited by 32